Aenitis Technologies

Aenitis Technologies is a Paris-based deeptech biotech company founded in 2014 by pioneers of acoustic levitation and fluid mechanics alongside biotech entrepreneur Emmanuel Vincent (CEO). The company develops and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. Using controlled ultrasonic waves, Aenitis' platform enables the contact-free, continuous manipulation of cells in fully sterile closed systems — supporting key unit operations including cell sorting, isolation, concentration, and washing at millifluidic scale (tens of milliliters per minute) without altering cell viability or functionality. Its flagship product, Mitis, is used across research, clinical, and industrial applications. The Modular Type Package (MTP) approach enables flexible integration of acoustic cell processing steps into existing GMP bioprocess workflows through co-development, licensing, or custom consumable integration. Aenitis has received support from the European Commission, the French Government, the European Investment Bank, and leading investors including Seventure Partners.